These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 18324888

  • 1. Current progress of DNA vaccine studies in humans.
    Lu S, Wang S, Grimes-Serrano JM.
    Expert Rev Vaccines; 2008 Mar; 7(2):175-91. PubMed ID: 18324888
    [Abstract] [Full Text] [Related]

  • 2. DNA vaccines for cancer.
    Boyd D, Hung CF, Wu TC.
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [Abstract] [Full Text] [Related]

  • 3. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM, Draghia-Akli R.
    Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956
    [Abstract] [Full Text] [Related]

  • 4. [DNA--the future in vaccine technology?].
    Kjeken R, Bogen B, Mathiesen I.
    Tidsskr Nor Laegeforen; 2006 Nov 16; 126(22):2964-8. PubMed ID: 17117196
    [Abstract] [Full Text] [Related]

  • 5. Gene-based vaccines: recent technical and clinical advances.
    Ulmer JB, Wahren B, Liu MA.
    Trends Mol Med; 2006 May 16; 12(5):216-22. PubMed ID: 16621717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of new technologies on vaccines.
    Talwar GP, Diwan M, Razvi F, Malhotra R.
    Natl Med J India; 1999 May 16; 12(6):274-80. PubMed ID: 10732430
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G, Cancer Vaccine Clinical Trial Working Group.
    J Immunother; 2007 Jan 16; 30(1):1-15. PubMed ID: 17198079
    [Abstract] [Full Text] [Related]

  • 10. Biotechnology and DNA vaccines for aquatic animals.
    Kurath G.
    Rev Sci Tech; 2008 Apr 16; 27(1):175-96. PubMed ID: 18666487
    [Abstract] [Full Text] [Related]

  • 11. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S, Nilsson B, Mellstedt H.
    Expert Rev Vaccines; 2005 Jun 16; 4(3):329-50. PubMed ID: 16026248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ, Schneider J.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y, Huang Z, Lin Y, Li J, Chou TH, Lu S, Wang S.
    Vaccine; 2008 Sep 19; 26(40):5145-52. PubMed ID: 18462847
    [Abstract] [Full Text] [Related]

  • 17. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May 19; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 18. Cancer vaccines: preclinical studies and novel strategies.
    Palena C, Abrams SI, Schlom J, Hodge JW.
    Adv Cancer Res; 2006 May 19; 95():115-45. PubMed ID: 16860657
    [Abstract] [Full Text] [Related]

  • 19. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH, Jin HT, Park SH, Youn JI, Sung YC.
    Vaccine; 2009 Sep 25; 27(42):5906-12. PubMed ID: 19651174
    [Abstract] [Full Text] [Related]

  • 20. Human clinical trials of plasmid DNA vaccines.
    Liu MA, Ulmer JB.
    Adv Genet; 2005 Sep 25; 55():25-40. PubMed ID: 16291211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.